Karst Peak Capital

We focus on public and private equity investments in companies in the consumer, healthcare, and technology sectors in Asia and Australasia Our investment approach is contrarian, fundamental, and long-term oriented, with an emphasis on identifying promising companies before they are well-known to the broader market Our largest exposure is to healthcare companies, with a particular interest in biotech, medical devices, diagnostics, and healthtech

Contrarian, fundamental, long-term investors since inception Invest primarily in Consumer, Healthcare, and Technology companies Leadership team has experience operating on the ground in Asia Pacific for over three decades Karst Peak has a presence on the ground in Hong Kong and Sydney

Flexibility To Invest In Both Public And Private Companies

Our goal is to build a concentrated portfolio of high-quality businesses that can compound value over a long period of time These companies should be run by passionate management teams with skin in the game

Brian Flannery-backed medical imaging company kicks off $15m pre-IPO

AI start-up merges with US health tech player ahead of IPO

The drug developer bucking the biotech sell-off

Neuren’s shares double on stunning drug trial results

Pharmaxis raising $9.2 million